Safety and Efficacy of Once-Daily Hydromorphone Extended-Release Versus Twice-Daily Oxycodone Hydrochloride Controlled-Release in Chinese Patients With Cancer Pain: A Phase 3, Randomized, Double-Blind, Multicenter Study-Reference-Cited by-同舟云学术

Safety and Efficacy of Once-Daily Hydromorphone Extended-Release Versus Twice-Daily Oxycodone Hydrochloride Controlled-Release in Chinese Patients With Cancer Pain: A Phase 3, Randomized, Double-Blind, Multicenter Study

Published:2014-08 Issue:8 Volume:15 Page:835-844
ISSN:1526-5900
Container-title:The Journal of Pain
language:en
Short-container-title:The Journal of Pain

Author:

Yu Shiying,Shen Wei,Yu Lu,Hou Yanyan,Han John,Richards Henry M.

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),Neurology

Reference25 articles.

1. A randomized study to demonstrate noninferiority of once-daily OROS(®) hydromorphone with twice-daily sustained-release oxycodone for moderate to severe chronic noncancer pain;Binsfeld;Pain Pract,2010

2. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain;Bruera;J Clin Oncol,1998

3. Cancer Pain Relief: With a Guide to Opioid Availability,1996

4. A systematic review of the associations between dose regimens and medication compliance;Claxton;Clin Ther,2001

5. Pain assessment: Global use of the Brief Pain Inventory;Cleeland;Ann Acad Med Singapore,1994

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shifting Views on Cancer Pain Management: A Systematic Review and Network Meta-Analysis;Journal of Pain and Symptom Management;2024-09

2. Efficacy and safety of hydromorphone for cancer pain: a systematic review and meta-analysis;BMC Anesthesiology;2024-08-09

3. Review of Opioid Abuse-Deterrent Formulations: Impact and Barriers to Access;Journal of Pain Research;2024-06

4. Opioid analgesics for nociceptive cancer pain: A comprehensive review;CA: A Cancer Journal for Clinicians;2023-12-18

5. The Use of Opioids in the Management of Chronic Pain: Synopsis of the 2022 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline;Annals of Internal Medicine;2023-03